We are proud to announce that Collegium has been named to USA TODAY’s Top Workplaces list for the second year in a row. This award speaks to our dedication to fostering a collaborative, transparent and respectful culture that is centered around our team and the communities we serve. Read more: https://bit.ly/3J5CbTD #TopWorkplacesUSA
Collegium Pharmaceutical, Inc.
制药业
Stoughton,Massachusetts 19,468 位关注者
Healthier people. Stronger communities.
关于我们
Collegium Pharmaceutical is building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a portfolio of differentiated medications to treat serious medical conditions.
- 网站
-
https://www.collegiumpharma.com
Collegium Pharmaceutical, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Stoughton,Massachusetts
- 类型
- 上市公司
- 领域
- Serious Medical Conditions、Responsible Pain Management、Attention Deficit Hyperactivity Disorder (ADHD)和Specialty Pharmaceutical
地点
Collegium Pharmaceutical, Inc.员工
动态
-
We warmly welcome Jane Gonnerman, David Dieter and Dean J. Patras to our Executive Team at this exciting time of growth and momentum for Collegium. Their contributions will support our mission to help improve the lives of people living with serious medical conditions.
-
-
In line with our commitment to leading with science, our medical team is on the ground at the National Association of Pediatric Nurse Practitioners (NAPNAP) 46th National Conference on Pediatric Health Care presenting two posters on real-world data in #ADHD. Learn more: https://bit.ly/41Fckuh
-
-
On #EmployeeAppreciationDay, we’d like to extend a huge shout out to the Collegium team for your ongoing passion and dedication to help make a positive difference in the lives of people living with serious medical conditions. Thank you to our amazing team!
-
We look forward to Collegium management participating in upcoming investor conferences this month. This is an exciting time for Collegium as we embark on our new phase of growth:?https://bit.ly/4kmuPwe
-
-
This afternoon, Collegium reported Q4 and full year 2024 financial results. Read the press release:?https://bit.ly/41lQImR
-
-
Today we published our 2024 ESG report, highlighting our mission to ‘Do Good as We Do Well’ and helping improve the lives of people living with serious medical conditions through our culture of responsibility and integrity, and desire to positively impact our communities. Thank you to our team for driving this mission each and every day. Read here:?https://lnkd.in/eMfaXTCv
-
-
Today is International Day of Women and Girls in Science. At Collegium, we are proud to endorse equitable access to #STEM education and help support the next generation of #WomenInScience. Hear from our team members on why these efforts are important to them and what it means to be #WomenInSTEM. #IDWGS
-
Welcome Nancy S. Lurker to Collegium’s Board of Directors. An accomplished leader with extensive expertise in driving commercial growth and strategic acquisitions, Nancy will be invaluable as we continue in our mission to help improve the lives of people living with serious medical conditions. Read here: https://bit.ly/4aLzqDK